Pilot randomised trial comparing the effect of different strengths of an antiseptic solution, chlorhexidine gluconate, on central venous catheter related infections in haemodialysis patients in three outpatient haemodialysis centres

Not Applicable

Completed

• Conditions: End stage renal disease; haemodialysis; central venous catheter infections; Urological and Genital Diseases; Complications of cardiac and vascular prosthetic devices, implants and grafts

• Registration Number: ISRCTN26577745
• Lead Sponsor: Trinity College Dublin (Ireland)

Brief Summary

2016 results in https://www.ncbi.nlm.nih.gov/pubmed/27079247 (added 17/01/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-31
• Study Completion: 2012-09-14
• Last Update Posted: 11 February 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

1. Patients over the age of 18 who require haemodialysis for end stage renal disease (ESRD)
2. Patients on long term haemodialysis using permanent tunnelled cuffed CVC
3. Patients whose permanent tunnelled cuffed CVC has been inserted at least four weeks prior to entry into the study (to avoid recruiting patients who may develop infection secondary to insertion technique)

Exclusion Criteria

1. Patients whose CVC is used for purposes other than access for haemodialysis
2. Patients with a known allergy to any component of the interventions
3. Patients whose CVC material is not compatible with interventions
4. Patients who are using central venous catheters or dressings which are not standard practice for the unit
5. Patients who are unable to give informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified